Group 1 - The provincial Food and Drug Inspection Research Institute has received a qualification recognition certificate from the provincial market supervision bureau, approving 17 new inspection parameters for biological products [1] - The total number of recognized inspection parameters for biological products has reached 101, indicating a new level of detection capability and technical proficiency for the institute [1] - The institute's advancements provide a solid technical foundation for the upcoming national batch release authorization for influenza vaccines and subsequent applications for blood product batch releases [1] Group 2 - Since the beginning of the 14th Five-Year Plan, the institute has actively developed its inspection and research capabilities for biological products, emphasizing the integration of research and inspection [1] - The biological products (pharmacology) laboratory has achieved significant breakthroughs in research project approvals, with multiple projects approved for 2024 and 2025, enhancing its research support capabilities [1] - For the 15th Five-Year Plan, the institute will focus on enhancing batch release capabilities and technical service platforms, while strengthening research teams and laboratory conditions [2]

Core Viewpoint - The event organized by Xiamen Food and Drug Quality Inspection Institute aimed to promote drug safety awareness through a community engagement initiative, integrating party building with health services [1][5]. Group 1: Event Overview - The event featured multiple functional areas, including a drug safety consultation zone where experts addressed public concerns about drug authenticity, proper usage, storage, and adverse reactions, particularly focusing on vulnerable groups like the elderly and children [1]. - A highlight of the event was the authenticity identification zone for precious medicinal materials, where professionals demonstrated how to distinguish between genuine and counterfeit products using traditional methods [1]. - The interactive experience area included a quiz on drug safety knowledge, making learning engaging for participants [1]. Group 2: Participation and Impact - The event lasted for three hours, distributing over 400 informational materials and receiving more than 200 public inquiries, with over 100 participants engaging in interactive experiences [3]. - Feedback from attendees indicated a strong appreciation for the practical advice provided, with one participant expressing a desire for more such events in the future [3]. Group 3: Future Plans - The institute's leadership emphasized that this event represents a practical implementation of integrating party building with business operations, aiming to convert professional advantages into effective services [5]. - Future initiatives will focus on innovating educational formats and expanding service channels to enhance public drug safety and contribute to the health development of Xiamen [5].

Core Viewpoint - The third "Lingnan Cup" pharmaceutical sampling skills competition was held in Guangzhou, emphasizing the importance of sampling techniques in ensuring drug safety and quality in the pharmaceutical industry [1][2]. Group 1: Competition Overview - The competition involved teams from 21 cities in Guangdong Province, focusing on both pharmaceuticals and cosmetics, with assessments on theoretical knowledge and practical sampling skills [1]. - Huang Ruitao from the Zhuhai Food and Drug Inspection Institute won the individual grand prize, while the Zhuhai team secured the group first prize [1]. Group 2: Industry Significance - The Deputy Director of the Guangdong Provincial Drug Supervision Administration highlighted that robust sampling techniques and skilled personnel are essential for maintaining drug safety and promoting high-quality development in the pharmaceutical industry [1]. - The competition aims to enhance learning and practical training, aligning with the strategic deployment of cultivating new productive forces and addressing the practical needs of drug regulation [1][2]. Group 3: Future Directions - The Guangdong Provincial Drug Inspection Institute plans to convert competition experiences into a regular training mechanism and operational guidelines to standardize the entire sampling process, thereby providing stronger technical support for public drug safety [2].